ClinicalTrials.gov
ClinicalTrials.gov Menu

Decitabine and Bortezomib in Treating Patients With Acute Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00703300
Recruitment Status : Completed
First Posted : June 23, 2008
Last Update Posted : November 7, 2014
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)